Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK9 | P45984 | 6/20 | 0.48 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.48 |
| ▸ | MAPK8 | P45983 | 3/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13658705 | 0.95 | MAPK9 (0.47) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL13658688 | 0.93 | MAPK9 (0.44) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL13015621 | 0.93 | KMT2A (0.47) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL24812260 | 0.92 | MAPK9 (0.43) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL13658715 | 0.92 | MAPK9 (0.43) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL24813354 | 0.92 | MAPK9 (0.43) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL24662789 | 0.91 | MAPK9 (0.56) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL10032666 | 0.88 | MAPT (0.45) | MAPK9MAPK10MAPK8CYP2C9RAB9A | |
| SCHEMBL13015625 | 0.86 | CYP11B1 (0.59) | CYP2C9RAB9ANPC1CYP1A2CYP2C19 | |
| SCHEMBL12571762 | 0.86 | MAPK9 (0.51) | MAPK9MAPK10MAPK8CYP1A2HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9887365-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-9887365-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-20160141513-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-20160141513-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-9296695-B2 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-29 | — | — | US | disclosed |
| US-9296695-B2 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-29 | — | — | US | disclosed |
| EP-2110373-B1 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO LTD (KR) | 2012-11-21 | — | — | EP | disclosed |
| EP-2110373-A1 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | Samsung Mobile Display Co., Ltd. (KR) | 2009-10-21 | — | — | EP | disclosed |
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-10-15 | — | — | US | disclosed |
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | OCIAD2, OCIAD1, DRD2 | MAPK9 996/4885MAPK10 3216/4885MAPK8 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.